Skip to main content
Shahky Early Access Program Now Available—Sign-up to Learn More
Shahky Early Access Program Now Available—Sign-up to Learn More
 

MedOncAlyzer 170

The MedOncAlyzer 170 panel leverages the proprietary Exosome Diagnostics technologies including total nucleic acid co-isolation (exoRNA and ctDNA), target capture and bioinformatics to yield unprecedented sensitivity and scope:

See the full 170 gene panel

To learn more about the MedOncAlyzer 170, please fill out the form below.

* indicates required fields